Literature DB >> 23817628

Induction and translocation of tissue transglutaminase isoforms increased phosphorylation in retinoic acid treated erythroleukemia cells.

Bassam M Fraij1.   

Abstract

Tissue transglutaminase (TGC, TG2, 80 kDa) is inactive in cross-linking reactions and is converted in vitro and in vivo to the TG (55 kDa) active isoform (Fraij in J Cell Biochem 112:2469-2489, 2011). Two isoforms of human TGC were cloned from human erythroleukemia (HEL) cells induced with retinoic acid (RA) and termed TGH, 63 kDa (Fraij et al. in J Biol Chem 267:22616-22673, 1992) and TGH2, 37 kDa. The purified TGC isoforms exhibited GTPase activity and TGH and TGH2 showed higher activities than the native TGC protein. In all normal cells examined, TGC was found in membrane fractions several fold higher than the supernatant fractions; however, in the natural tumor cell line HEL the TGC cellular distribution was reversed. Although TGC is the major enzyme in normal human erythrocytes, its expression level was significantly decreased in HEL cells. RA treatment induced a sevenfold increase in the level of TGC protein in HEL cells and was accompanied by its translocation to cell membranes. When isolated membrane and supernatant fractions from normal human foreskin (CF3), normal human embryonic lung (WI-38), and HEL cells treated with or without RA were incubated with [(32)P]-ATP at 37 °C for 1 h, more radio-labeled proteins were detected in the membrane fractions than the cytosolic fractions. More labeled protein bands were detected in RA treated HEL cells in comparison to control HEL cell extracts. Radio labeled proteins coimmunoprecipitated with the TGC isoforms in RA treated HEL membrane fractions thereby confirming that the radio-labeled material consists of endogenous proteins associated with TGC isoforms. Protein phosphorylation is related to the induction and translocation of the isoforms in RA treated cells. These results show that the TGC isoforms complexes with proteins in vivo and that the phosphorylation of these proteins is catalyzed directly by TGC kinase activity or indirectly by the TGC phosphorylation of other protein kinases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23817628     DOI: 10.1007/s10930-013-9499-9

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  32 in total

1.  Transactivation via RAR/RXR-Sp1 interaction: characterization of binding between Sp1 and GC box motif.

Authors:  J Shimada; Y Suzuki; S J Kim; P C Wang; M Matsumura; S Kojima
Journal:  Mol Endocrinol       Date:  2001-10

Review 2.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

3.  GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.

Authors:  Lei Xu; Shahinoor Begum; Jeremy D Hearn; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-06       Impact factor: 11.205

4.  "Activation of tissue tranglutsaminase by removal of carboxyl-terminal peptides".

Authors:  Bassam M Fraij
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

5.  Regulation of transglutaminase-mediated hepatic cell death in alcoholic steatohepatitis and non-alcoholic steatohepatitis.

Authors:  Soichi Kojima; Ting-Fang Kuo; Hideki Tatsukawa
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

6.  Interaction site of GTP binding Gh (transglutaminase II) with phospholipase C.

Authors:  K C Hwang; C D Gray; N Sivasubramanian; M J Im
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

7.  Site-directed mutagenesis of human tissue transglutaminase: Cys-277 is essential for transglutaminase activity but not for GTPase activity.

Authors:  K N Lee; S A Arnold; P J Birckbichler; M K Patterson; B M Fraij; Y Takeuchi; H A Carter
Journal:  Biochim Biophys Acta       Date:  1993-09-03

8.  Differential expression of transglutaminase in human erythroleukemia cells in response to retinoic acid.

Authors:  T Suedhoff; P J Birckbichler; K N Lee; E Conway; M K Patterson
Journal:  Cancer Res       Date:  1990-12-15       Impact factor: 12.701

9.  A third human tissue transglutaminase homologue as a result of alternative gene transcripts.

Authors:  B M Fraij; R A Gonzales
Journal:  Biochim Biophys Acta       Date:  1996-04-10

Review 10.  TGM2 and implications for human disease: role of alternative splicing.

Authors:  Thung-S Lai; Charles S Greenberg
Journal:  Front Biosci (Landmark Ed)       Date:  2013-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.